Skip to main content
. 2020 Nov 23;12(11):3486. doi: 10.3390/cancers12113486

Table 3.

Plasma ctDNA results at time of cessation relative to clinical outcome.

Ongoing Response (n) Disease Progression (n) Total (n)
ctDNA detectable 1 4 5
ctDNA undetectable 27 6 33
Total 28 10 38